- Filed
- May 6, 2026 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 6, 2026 | 979.95M sh |
| Capex | Q1 2026 · Mar 31, 2026 | $60K |
| Capex | Q1 2026 · Mar 31, 2025 | $280K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$5.26M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$6.65M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $9.37M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $9.02M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $110.95M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $115.4M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $132.44M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $195.66M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $8.56M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $9.45M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $10.59M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $11.64M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $60.03M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $64.04M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $121.53M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $127.04M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $0.00 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$0.07 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $0.00 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$0.07 |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $1.15M |
| Rd Expense | Q1 2026 · Mar 31, 2025 | $1.85M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$4.53M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$63.81M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$4.9M |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$64.55M |
| Gross Profit | Q1 2026 · Mar 31, 2026 | $5.48M |
| Gross Profit | Q1 2026 · Mar 31, 2025 | $4.41M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $3.32M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2025 | $2.09M |
| Revenue | Q1 2026 · Mar 31, 2026 | $8.8M |
| Revenue | Q1 2026 · Mar 31, 2025 | $6.5M |